Iron Citrate (Synthesit) Supplementation During Pancreas Cancer Showed Surprising Results – Case Study

Analyses of blood plasma proteins done in December 2019 and March 2023. Parameters that were out of the reference range are highlighted. Values marked as dash mean no data available.

December 2019				March 2023
Fraction	%	Reference range %	g/l	g/l	Reference range
Albumin	62.9	60.3 – 72.8	44.0	41.4	37.5 – 50.1
Alpha1-globulins	2.2	1.0 – 2.6	1.5	3.0	1.9 – 4.6
Alpha2-globulins	8.6	7.2 – 11.8	6.0	6.1	4.8 – 10.5
Beta1-globulins	6.0	5.6 – 9.1	4.2	-	-
Beta2-globulins	3.3	2.2 – 5.7	2.3	-	-
Beta-globulins	-	-	-	6.8	4.8 – 11.0
Gamma-globulins	17.0>	6.2 – 15.4	11.9	11.7	6.2 – 15.1
Albumin/Globulin ratio	1.70	1.2 – 2.0	-	1.5	1.2 – 2.0
Monoclonal IgG kappa	0.9	-	0.6	-	-
Total protein	69.9	62 – 81	-	67	62 – 81

Comparison of various haematological parameters

Table 2

Blood analyses before taking Synthesit in February 2020, during taking in July 2021, and after taking it in March 2023. Parameters that were out of the reference range are highlighted. Values marked as dash mean no data available.

Parameter	Before taking Synthesit 02/2020	During taking Synthesit 7/2021	After taking Synthesit 03/2023	Reference range	Unit of measurement
Haematocrit	40.9	-	42.7	35.0 – 47.0	%
Haemoglobin	14.0	14.8	14.5	11.7 – 16.0	g/dl
Erythrocytes	4.58	4.90	4.72	3.80 – 5.30	*10⁶/μl
Thrombocytes	116	260	123	150 – 400	*10³/μl
Leukocytes	7.07	4.20	6.80	4.50 – 11	*10³/μl
Neutrophils (total), %	40.30	66	48.40	48.0 – 78.0	%
Lymphocytes, %	50.5	-	44.1	19.0 – 37.0	%
Monocytes, %	7.5	-	5.6	3.0 – 11.0	%
Eosinophils, %	1.4	3	1.6	1.0 – 5.0	%
Basophils, %	0.3	-	0.3	<1.0	%
Neutrophils abs.	2.85	-	3.29	1.56 – 6.13	*10³/μl
Lymphocytes abs.	3.57	-	3.00	1.18 – 3.74	*10³/μl
Monocytes abs.	0.53	1	0.38	0.20 – 0.95	*10³/μl
Eosinophils abs.	0.10	-	0.11	0.00 – 0.70	*10³/μl
Basophils abs.	0.02	-	0.02	0.00 – 0.20	*10³/μl
Erythrocyte Sedimentation Rate (ESR)	12	4	7	<30	mm/h